Introduction
Development of an iatrogenic aorto-right atrial fistula is a rare but clinically relevant complication of cardiac surgery. 1 Transfemoral percutaneous closure is considered a suitable alternative to surgical repair. [2] [3] [4] [5] This is the first report to cover percutaneous closure using complete arm access.
Learning points
• Iatrogenic fistula of the non-coronary cusp during mitral valve replacement is a rare, but clinically relevant complication. 
Timeline Case presentation
A 44-year-old Asian woman was referred to our hospital with 15-year history of chronic heart failure. She was New York Heart Association functional classification Class III. She had undergone surgical mitral valve replacement (MVR) using a 29 mm St. Jude Medical bileaflet mechanical prosthesis at the age of 29 to address rheumatic mitral stenosis. She had been complaining of exertional dyspnoea. On physical examination, a high-pitched, grade 5/6 systolic and 3/6 diastolic murmur was detected at the left parasternal border. There were no clinical signs or symptoms of endocarditis or haemolysis. The patient was on Vitamin K anticoagulant (phenprocoumon). Transthoracic echocardiography (TTE) revealed a normal left ventricular, end-diastolic diameter of 48 mm and systolic function (ejection fraction 70%), abnormal left atrial dimensions, volume index of 75 mL/m 2 (22-52 mL) after MVR, a dilated right ventricle with an end-diastolic diameter (RVEDD) at the base of 57 mm (< _41 mm) with normal right ventricular systolic function, a dilated right atrium (RA) with end-systolic area 32 cm 2 (< _18 cm 2 ), mild aortic regurgitation, and severe tricuspid regurgitation (TR) with an estimated pulmonary artery systolic pressure (PASP) of 58 mmHg (< _36 mmHg). Transoesophageal echocardiography (TOE) with colour Doppler flow revealed a continuous shunting from the non-coronary cusp (NCC) through a fistula into the enlarged RA without aneurysm formation ( Figure 1 , Supplementary material online, Video S1).
Further evaluation and both left and right heart catheterization were performed with our preferred access sites, the right radial artery and the right basilic vein. There was a 13% step-up in the oxygen saturation in the RA, from 65% in the superior vena cava (SVC) to 78%. Aortography revealed a torrential flow from the NCC of sinus of Valsalva towards the RA (Figure 2 , Supplementary material online, Video S2). The final calculated ratio of pulmonary to systemic circulation (Qp:Qs) was 1.6:1. Due to heart failure caused predominantly by relevant left-to-right shunting and right heart enlargement the patient was advised to opt between percutaneous closure or surgical repair.
After detailed discussion with the patient and her family, the patient opted for percutaneous closure. The patient further requested the procedure be performed through the same access route as the diagnostic aortography. We decided to use a complete arm access. The procedure was performed under general anaesthesia. Both radial arteries were accessed with a 5 Fr Glidesheath slender sheath (Terumo Corporation, Somerset, NJ, USA). The right basilic vein was punctured under ultrasound guidance and exchanged for a 6 Fr 90 cm angulated tip destination sheath (Terumo Corporation). A 5 Fr pigtail catheter was negotiated from the left radial artery into the ascending aorta to perform aortography. A 5 Fr MP-II-guide catheter (Medtronic, Minneapolis, MN, USA) was negotiated from the right radial artery, which was advanced under TOE and fluoroscopic guidance through the fistula towards the RA ( Figure 3A ). An angled hydrophilic 0.035 00 Glidewire (Terumo Corporation) was advanced from the aorta into the SVC. The glidewire was snared with a 20 mm Gooseneck snare (eV3, Plymouth, MN, USA) ( Figure 3B ) and externalized through the right basilic vein access site making a complete arteriovenous loop. The MP-II-guide catheter was negotiated towards the inner lumen of the destination sheath, which facilitated the advancement of the sheath through the fistula into the right subclavian artery (mother-child technique, Figure 3C ). The glidewire and the guidecatheter were removed from the right radial artery. Guided by fluoroscopy and TOE, the left lobe of an 10 mm Amplatzer Vascular Plug (AVP) II (Abbott, Abbott Park, IL, USA) was partially deployed in the right subclavian artery. The whole assembly was retracted to the NCC level. We excluded residual shunting along the fistula using TOE and aortography and then performed a tug test. The middle lobe and the right disc were released with an excellent coaxial alignment of the device to the NCC and the RA ( Figure 4A -C, Supplementary material online, Video S3). Phenprocoumon was continued. Dual antiplatelet therapy (DAPT) was given for 4 weeks in combination with a proton pump inhibitor.
The patient was discharged without any further complications. TTE at 3 months revealed significant improvement of right heart dimensions under residual mild TR (PASP 31 mmHg, RVEDD 45 mm, RA 19 cm 2 ) and no increase in aortic regurgitation. The patient remained asymptomatic as of a 3-month follow-up.
Discussion
After discussion among the heart team, we strongly considered an iatrogenic cause of the fistula of the NCC. Because the symptoms occurred just after MVR, the fistula was probably created iatrogenically during suturing of the mitral valve prothesis, which presumably pierced the NCC. The development of an iatrogenic defect of the NCC during MVR is a rare though clinically relevant complicaton.
Registry data and case reports consider surgical repair of the firstline treatment for ruptured sinus of Valsalva aneurysm (RSVA) with low mortality rate.
The first percutaneous closure of RSVA was reported by Cullen et al.
2 in 1994 using a Rashkind umbrella device. Since then, few case reports or case series covering this technique have been reported with encouraging follow-up results, and percutaneous closure of RSVA as well as aortocardiac fistula via femoral approach has been shown to be a suitable alternative to surgery in appropriately selected patients. [3] [4] [5] Considering the longstanding nature of the disease, specifically the low risk of rupture of the NCC due to well ingrown sutures of the mitral valve prosthesis, the percutaneous approach via total arm access is a suitable therapeutic option as compared to femoral access. 1 For coronary interventions, radial access is associated with fewer complications, early ambulation, reduced costs, reduced morbidity, and improved clinical outcomes. 6 A technical advantage of deploying the device through the externalized wire via arm access provides enhanced support via the AV loop. The relative low profile of the AVP II allows for delivery by the basilic vein route. Although, in most cases, the 5-7 Fr delivery sheath is sufficient, larger defects necessitating larger devices that require an 8 Fr delivery sheath may limit device delivery by the basilic vein. However, selective venography could be helpful for guide sizing of the vein. Device-related thrombosis is rare after a percutaneous procedure, but it can involve serious complications. To prevent thrombembolism, the preprocedural regimen of phenprocoumon was continued without interruption with a target international normalized ratio (INR) of 2-2.5. During the procedure the patient received additional unfractionated heparin. After the procedure, she was treated with DAPT with aspirin (100 mg per day), clopidogrel (75 mg per day), and coadministration of a proton pump inhibitor. DAPT was discontinued on clinical and echocardiographic follow-up after 4 weeks, and oral vitamin K antagonist therapy was continued with a target INR of 3.0. We acknowledge that optimum pharmacological treatment after shunt device implantation in patients requiring anticoagulation is not fully established.
In some patients, this approach is an attractive alternative to femoral access with high technical success and good short-term outcome; however, long-term follow-up is absolutely necessary.
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